ATE295160T1 - Zusammensetzungen enthaltend isovalerianamide zusammen mit ibuprofen - Google Patents

Zusammensetzungen enthaltend isovalerianamide zusammen mit ibuprofen

Info

Publication number
ATE295160T1
ATE295160T1 AT99909827T AT99909827T ATE295160T1 AT E295160 T1 ATE295160 T1 AT E295160T1 AT 99909827 T AT99909827 T AT 99909827T AT 99909827 T AT99909827 T AT 99909827T AT E295160 T1 ATE295160 T1 AT E295160T1
Authority
AT
Austria
Prior art keywords
valerian
isovalerianamide
ibuprofen
compositions containing
treatment
Prior art date
Application number
AT99909827T
Other languages
English (en)
Inventor
Linda D Artman
Manuel F Balandrin
Original Assignee
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Pharma Inc filed Critical Nps Pharma Inc
Application granted granted Critical
Publication of ATE295160T1 publication Critical patent/ATE295160T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99909827T 1998-03-04 1999-03-04 Zusammensetzungen enthaltend isovalerianamide zusammen mit ibuprofen ATE295160T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7673798P 1998-03-04 1998-03-04
PCT/US1999/004786 WO1999044623A1 (en) 1998-03-04 1999-03-04 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid

Publications (1)

Publication Number Publication Date
ATE295160T1 true ATE295160T1 (de) 2005-05-15

Family

ID=22133883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99909827T ATE295160T1 (de) 1998-03-04 1999-03-04 Zusammensetzungen enthaltend isovalerianamide zusammen mit ibuprofen

Country Status (8)

Country Link
EP (1) EP1059930B1 (de)
JP (1) JP2002505296A (de)
AT (1) ATE295160T1 (de)
AU (1) AU2894599A (de)
CA (1) CA2321737A1 (de)
DE (1) DE69925251T2 (de)
ES (1) ES2242385T3 (de)
WO (1) WO1999044623A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589994B1 (en) 1996-08-30 2003-07-08 Nps Pharmaceuticals, Inc. Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound
US7235258B1 (en) * 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
US7205151B2 (en) 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7901714B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US7270835B2 (en) 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8168234B2 (en) 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7901713B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US7718198B2 (en) 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US8206753B2 (en) 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
KR20050071605A (ko) 2002-10-21 2005-07-07 메타프로테오믹스, 엘엘씨 염증반응과 관련된 병리학적 상태를 치료하거나 저해하는조성물
KR20060105429A (ko) * 2003-05-22 2006-10-11 메타프로테오믹스, 엘엘씨 염증을 약화시키기 위한 항염증성 약제학적 조성물 및 위의독성의 치료법 또는 예방법
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
WO2007021694A2 (en) 2005-08-09 2007-02-22 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
WO2007023896A1 (ja) * 2005-08-26 2007-03-01 Calpis Co., Ltd. 筋肉痛抑制剤及び筋肉痛抑制用機能性食品
WO2008140842A1 (en) 2007-05-11 2008-11-20 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
KR102346511B1 (ko) * 2019-02-27 2022-01-03 종근당건강 주식회사 타라곤(Tarragon, Little Dragon, Mugwort, Estragon) 추출물을 함유하는 근육질환 예방 또는 치료용 조성물
KR102320221B1 (ko) * 2020-01-21 2021-10-29 한국식품연구원 쥐오줌풀 추출물을 유효성분으로 포함하는 근육 질환 예방, 개선 또는 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617555C3 (de) * 1966-04-19 1974-09-19 Kali-Chemie Ag, 3000 Hannover Verfahren zur Isolierung von therapeutisch wertvollen Isovaleriansäureestern aus Valeriana- und Kentranthus-Extrakten
DE2230626B2 (de) * 1972-06-22 1978-07-20 Roland Dr. 7967 Bad Waldsee Schaette Baldrianpräparat
US5506268A (en) * 1993-06-11 1996-04-09 Nps Pharmaceuticals, Inc. Use of isovaleramide as a mild anxiolytic and sedative agent
CN1051674C (zh) * 1995-11-28 2000-04-26 邵东英 高能饼干及其生产方法
CN1160513A (zh) * 1996-03-21 1997-10-01 成都华福宁制药总厂 可乐型饮料
IL128724A (en) * 1996-08-30 2003-05-29 Nps Pharma Inc Pharmaceutical compositions containing isovaleric acid derivatives for treating various neurological pathologies

Also Published As

Publication number Publication date
EP1059930A1 (de) 2000-12-20
CA2321737A1 (en) 1999-09-10
WO1999044623A8 (en) 1999-10-14
ES2242385T3 (es) 2005-11-01
EP1059930B1 (de) 2005-05-11
DE69925251T2 (de) 2006-01-26
DE69925251D1 (de) 2005-06-16
AU2894599A (en) 1999-09-20
JP2002505296A (ja) 2002-02-19
WO1999044623A1 (en) 1999-09-10

Similar Documents

Publication Publication Date Title
ATE295160T1 (de) Zusammensetzungen enthaltend isovalerianamide zusammen mit ibuprofen
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
HRP20020088B1 (en) Levodopa/carbidopa/entacapone pharmaceutical preparation
CA2274074A1 (en) Novel compounds with analgesic effect
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
CY2562B1 (en) Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances
HK1035142A1 (en) Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent.
IL128724A0 (en) Use of isovaleric acid derivatives for treating spasticity and convulsions
ES2109131B1 (es) Composicion farmaceutica que tiene actividad analgesica.
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
DE3366910D1 (en) Pharmaceutical compositions and preparation thereof
KR900005974A (ko) 남성의 성기능 장애 치료제
PL348202A1 (en) Pharmaceutically active composition and dispensing device
IL70407A (en) Synergistic analgesic pharmaceutical compositions in unit dosage form,comprising an analgesic agent and hydroxyzine
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
KR830008678A (ko) 진통 조성물
ATE270095T1 (de) Arzneimittel zur anwendung im mund
SE9700617D0 (sv) New composition
WO2001028566B1 (en) Use of acetyl salicilyc acid for the treatment of benign prostate hyperplasia
CO4910116A1 (es) Formulacion de liberacion controlada para farmacos basicos escasamente solubles
IT1150451B (it) Composizione farmaceutica ad attivita'analgesica,antiretica e antiinfiammatoria e procedimento per la preparazione del principio attivo
KR970000231A (ko) 진통소염제의 의약조성물
RU93055153A (ru) Антибактериальное средство "анальгин"
HU0800735D0 (hu) Orálisan adagolható, azonnali és nyújtott hatóanyag-felszabadítású, felszívódást elõsegítõ szert tartalmazó galenusi készítmény és ezen felszívódást elõsegítõ szer alkalmazása
RU96113328A (ru) Способ торможения фиброзообразования

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties